SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,231.00    7.00 (0.57%)
Bid:
1,229.00
Ask:
1,230.00
Spread: 1.00 (0.081%)
Market Cap: £858.56m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Trading update and Acquisitions

25 Jul 2011 07:00

RNS Number : 9327K
CVS Group plc
25 July 2011
 



Immediate Release

25 July 2011

 

 

CVS Group plc

 

Trading update and Acquisitions

 

The Board is pleased to announce that it expects results for the year ended 30 June 2011 to be in line with market expectations. Like for like turnover for the year showed growth in the region of +0.4%, with the second half delivering like for like sales growth in the region of +3%.

 

The Board is also pleased to report further acquisition activity in the second half of the financial year, with RH Campbell, Attimore and Clarendon House veterinary clinics being added to the Group's practice division. Net debt at 30 June was in line with market expectations, being in the region of £34 million, after having funded these acquisitions.

 

RH Campbell is a single site practice in Swansea acquired in January 2011. The turnover of the practice for the year ended 30 November 2010 was in the region of £0.3 million.

 

Attimore Veterinary Group is a five site practice in and around the Welwyn Garden City area acquired in April 2011. The turnover of the practice for the year ended 30 November 2010 was in the region of £1.3 million.

 

Clarendon House Veterinary Group is a three site practice in and around the Chelmsford area acquired in May 2011. The turnover of the practice for the year ended 30 September 2010 was in the region of £1.1 million.

 

All three acquisitions provide a good geographical fit with the Group's existing surgery locations.

 

In total the Group now operates 223 surgeries, 6 diagnostic laboratories, 1 pet crematorium and an online dispensary across the UK and remains the largest operator in a highly fragmented market.

 

The Board of Directors confirms that the preliminary results for the year ended 30 June 2011 will be announced on Tuesday 27 September 2011.

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Paul Coxon - Finance Director

 

Buchanan Communications: 020 7466 5000

Richard Oldworth

Christian Goodbody

 

Brewin Dolphin Investment Banking: 0845 059 6412

Nick Owen

Matt Davis

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFEDEIFFIL
Date   Source Headline
12th Jun 202611:08 amRNSHolding(s) in Company
12th Jun 202610:06 amRNSHolding(s) in Company
8th Jun 20262:43 pmRNSStandard form for notification of major holdings
8th Jun 20262:41 pmRNSUpdated: Transaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTotal Voting Rights
28th May 20267:00 amRNSPDMR Dealing
26th May 20267:02 amRNSChanges to NEDs' Responsibilities
26th May 20267:01 amRNSCommencement of Share Buyback Programme
26th May 20267:00 amRNSRefinancing, Launch of SBB and Acquisition
8th May 20263:55 pmRNSStandard form for notification of major holdings
30th Apr 20267:00 amRNSTotal Voting Rights
21st Apr 202612:46 pmRNSNon-Executive Director Appointment
20th Apr 20264:45 pmRNSStandard form for notification of major holdings
31st Mar 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSCEO retirement
25th Mar 20267:00 amRNSNon-Executive Director Changes
24th Mar 20267:13 amRNSResponse to CMA Summary Final Decision Report
27th Feb 20267:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSInterim Results
30th Jan 20267:00 amRNSTotal Voting Rights
29th Jan 20262:02 pmRNSStandard form for notification of major holdings
29th Jan 20268:00 amRNSReadmission - CVS Group Plc
29th Jan 20267:00 amRNSAdmission to Trading on the Main Market of the LSE
28th Jan 20267:08 amRNSResponse to DEFRA consultation
27th Jan 20262:31 pmRNSStandard form for notification of major holdings
23rd Jan 202612:19 pmRNSPublication of Prospectus and Trading Update
23rd Jan 20267:00 amRNSProgramme completion and transaction in own shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20269:51 amRNSStandard form for notification of major holdings
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20264:24 pmRNSStandard form for notification of major holdings
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSBlock Listing Interim Review
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20264:31 pmRNSStandard form for notification of major holdings
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20269:34 amRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.